<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00800527</url>
  </required_header>
  <id_info>
    <org_study_id>B4ISM4350015-009/295</org_study_id>
    <nct_id>NCT00800527</nct_id>
  </id_info>
  <brief_title>Efficacy of Gabapentin in the Treatment of Chest Pain and Paresthesia in Patients With Sternotomy</brief_title>
  <official_title>Phase 4 Study of Efficacy of Gabapentin in the Treatment of Chest Pain and Paresthesia in Patients With Sternotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Usak State Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Usak State Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators aim to demonstrate the efficacy of gabapentin compared with
      diclofenac in the treatment of chronic non-ischemic chest pain and paresthesia of the
      patients with sternotomy and to elucidate the similarities of PCPP to neuropathic pain
      syndromes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Because the primary objective of this study is to evaluate the effect of different drugs on
      chest pain and paresthesia, we choose the prospective, randomized, open label, blinded end
      point design for this study. According to this design, both patients and physicians making
      first assessment are aware of the treatment but the investigators making second and third
      assessment are blinded to treatment. Therefore, two separate cardiovascular surgeons wil
      select and randomize the patients and a cardiologist blinded to treatment assignments will
      evaluate the patients at second interview at thirty day and 3 months later. The study was
      approved by the Local Ethics Committee and informed consent was obtained from each patient.
      The study was conducted in Usak State Hospital with collaboration the Department of
      Cardiology of Ataturk Education and Training Hospital.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of pain or paresthesia severity</measure>
    <time_frame>one month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>duration of relief of pain or paresthesia</measure>
    <time_frame>three month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Chest Pain</condition>
  <condition>Paresthesia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Gabapentin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Diclofenac</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
    <description>Gabapentin 800 mg one a day up to 30 day</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Group-1: Gabapentin Arm</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac</intervention_name>
    <description>Diclofenac 75 mg one a day up to 30 day</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Group-2: Diclofenac arm</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Poststernotomy chest pain and/or paresthesia

        Exclusion Criteria:

          -  Osteoporosis, renal function impairment (creatinine value &gt;1.5 mg / dl.)

          -  Hepatic dysfunction, peptic ulcer, chest pain with ischemic origin, pediatric cases

          -  Over production of scar tissue, thoracic surgery other than sternotomy -

          -  Redo-bypass surgery, infection, sternal dehiscence,valve surgery together with bypass
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ismail BIYIK, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Investigator</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Usak State Hospital</name>
      <address>
        <city>Usak</city>
        <zip>64100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2008</study_first_submitted>
  <study_first_submitted_qc>December 1, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2008</study_first_posted>
  <last_update_submitted>December 1, 2008</last_update_submitted>
  <last_update_submitted_qc>December 1, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2008</last_update_posted>
  <responsible_party>
    <name_title>Ismail BIYIK</name_title>
    <organization>Investigator</organization>
  </responsible_party>
  <keyword>sternotomy</keyword>
  <keyword>pain</keyword>
  <keyword>paresthesia</keyword>
  <keyword>Poststernotomy chest pain</keyword>
  <keyword>Poststernotomy chest paresthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chest Pain</mesh_term>
    <mesh_term>Paresthesia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>gamma-Aminobutyric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

